StockData
Haleon plc logo

Haleon plc (HLNCF) stock

HLNCFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31Also trades as HLN
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$4.96+0.01 (+0.20%)

Close on Oct 19, 2026Market cap $22.20BP/E 10.0Yield –

Haleon plc saw revenue fall 1.8% to £11.03B over fiscal 2025. Operating income rose 9.3% to £2.41B, moving the operating margin from 19.6% to 21.9%. Free cash flow was £2.31B, up 12.7% from a year earlier. At the latest close the market valued the company at £16.60B, 10.0 times its earnings.

Revenue
£11.03B
-1.8% vs. a year earlier
Operating income
£2.41B
+9.3% vs. a year earlier
Free cash flow
£2.31B
+12.7% vs. a year earlier
EPS, diluted
0.18 GBP
+17.8% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026

Valuation

Market cap
£16.60B
P/E ratio
10.0
Price to sales
1.50
Price to book
1.01
Dividend yield
–
Free cash flow yield
13.93%

Fundamentals

Revenue
£11.03B
Net income
£1.67B
EPS, diluted
0.18 GBP
Free cash flow
£2.31B

Trading

Previous close
$4.95
Open
$4.85
Day's range
$4.85 – $4.97
Volume
2,098
Average volume (20 days)
33,562
Beta (5 years)
0.15
RSI (14 days)
33.1
Volatility (1 year)
27.4%
Relative volume
2.31×
WACC
6.7%

Market cap history

Month-end market cap since 2022, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodHLNCFS&P 500DifferenceHLNCF per yearS&P 500 per year
1 month+10.0%+0.6%+9.3 pts
3 months-0.5%+3.4%−3.9 pts
Year to date+1.2%+13.3%−12.1 pts
1 year+7.4%+16.6%−9.2 pts
3 years+33.3%+86.4%−53.1 pts+10.0%+23.1%

Six years at a glance

Fiscal years 2020 to 2025, GBP

Revenue

£11.03B-1.8% YoY

Gross profit

£7.08B+3.8% YoY

Operating income

£2.41B+9.3% YoY

Net income

£1.67B+15.6% YoY

EPS, diluted

0.18 GBP+17.8% YoY

Free cash flow

£2.31B+12.7% YoY
Reported period

Press releases

Releases Haleon filed with the SEC as exhibits to Form 8-K or 6-K

  1. Six months ended 30 June 2026
    6-K
  2. Twelve months ended 31 December 2024 (unaudited)
    6-K
  3. 6-K exhibit EX-99.1
    6-K
  4. Six months ended 30 June 2024
    6-K
  5. Three months ended 31 March 2024
    6-K
  6. PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
    6-K
All press releases and earnings

About Haleon

Perfumes, Cosmetics & Other Toilet Preparations

Haleon operates as a consumer healthcare company offering products across oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. The business delivers therapeutic skin health treatments, over-the-counter wellness solutions, and personal care products under brands such as Nexium, ChapStick, and Preparation H to individual consumers globally.

Company profile, executives and history

Haleon stock: common questions

What is Haleon's stock price?

HLNCF closed at $4.96 on Oct 19, 2026, up 0.20% on the day.

What is Haleon's market cap?

Haleon was worth $22.20B at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is HLNCF's P/E ratio?

HLNCF trades at 10.0 times earnings, based on diluted earnings per share of 0.18 GBP over fiscal 2025.

How much revenue does Haleon make?

Haleon reported revenue of £11.03B for fiscal 2025, down 1.8% from a year earlier.

Does Haleon pay a dividend?

No. Haleon has not paid a cash dividend over the last twelve months.

How has HLNCF stock performed over the past year?

Including dividends, HLNCF returned +7.4% over the past year, against +16.6% for the S&P 500.

Who are Haleon's competitors?

Companies most similar to Haleon by business, industry and size include KVUE, CL, EL, COTY, YSG.